| 
			1 | 
		
			
									
						Overcoming solid tumor resistance to T cell recruiting bispecific antibodies by providing co-stimulation and checkpoint inhibition at the tumor site Warwas, Karsten M.. - Heidelberg, 2022
					
							 | 
									
			
								
															  
																  
										
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			2 | 
		
			
									
						Balancing efficacy and selectivity of bispecific c-METxEGFR antibodies Sellmann, Carolin. - Darmstadt, 2016
					
							 | 
									
			
								
															  
																  
										
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			3 | 
		
			
									
						Humanization, optimization and preclinical characterization of bispecific Endoglin antibodies for tumor-cell restricted activation of NK-cells Pflügler, Martin Sebastian. - Tübingen, 2016
					
							 | 
									
			
								
															  
																  
										
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			4 | 
		
			
									
						Anti-tumor activity, pharmacology and toxicology of EpCAM-, CD3-bispecific single-chain antibodies Amann, Maria, 2009
					
							 | 
									
			
								
															  
																  
										
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			5 | 
		
			
									
						Aspects of the mode of action of bispecific T cell engager (BiTE) antibodies Hauff, Cornelia, 2009
					
							 | 
									
			
								
															  
																  
										
								
			 | 
		
		
			
			 
			
					    					 
							
			 | 
			6 | 
		
			
									
						Retargeting of cytokine induced killer cells against B-cell neoplasms using bispecific antibodies for adoptive immunotherapy Tita-Nwa, Dinga Nkom Freddy, 2006
					
							 | 
									
			
								
															  
																  
										
								
			 |